Acumen Pharmaceuticals, Inc.·4

Jan 23, 5:06 PM ET

Siemers Eric 4

4 · Acumen Pharmaceuticals, Inc. · Filed Jan 23, 2025

Insider Transaction Report

Form 4
Period: 2025-01-21
Siemers Eric
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2025-01-21$1.59/sh3,219$5,118170,298 total
Footnotes (1)
  • [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024.

Documents

1 file
  • 4
    wk-form4_1737670003.xmlPrimary

    FORM 4